Treatment of Vertigo
| Agenta | Doseb |
|---|---|
| Antihistamines | |
| Meclizine | 25-50 mg three times daily |
| Dimenhydrinate | 50 mg one to two times daily |
| Promethazine | 25 mg two to three times daily (also can be given rectally and IM) |
| Benzodiazepines | |
| Diazepam | 2.5 mg one to three times daily |
| Clonazepam | 0.25 mg one to three times daily |
| Anticholinergic | |
| Scopolamine transdermalc | Patch |
| Physical therapy | |
| Repositioning maneuversd | |
| Vestibular rehabilitation | |
| Other | |
| Diuretics and/or low-sodium (1000 mg/d) diete | |
| Antimigrainous drugsf | |
| Methylprednisoloneg | 100 mg daily days 1-3; 80 mg daily days 4-6; 60 mg daily days 7-9; 40 mg daily days 10-12; 20 mg daily days 13-15; 10 mg daily days 16-18, 20, 22 |
| Selective serotonin reuptake inhibitorsh |
aAll listed drugs are approved by the U.S. Food and Drug Administration, but most are not approved for the treatment of vertigo.
bUsual oral (unless otherwise stated) starting dose in adults; a higher maintenance dose can be reached by a gradual increase.
cFor motion sickness only.
dFor benign paroxysmal positional vertigo.
eFor Ménière's disease.
fFor vestibular migraine.
gFor acute vestibular neuritis (started within 3 days of onset).
hFor psychosomatic vertigo.